Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Revenue

Advent Pharma had revenue of 127.46M BDT in the quarter ending March 31, 2025, a decrease of -17.42%. This brings the company's revenue in the last twelve months to 478.96M, down -15.79% year-over-year. In the fiscal year ending June 30, 2024, Advent Pharma had annual revenue of 571.67M with 2.44% growth.

• Revenue (ttm): 478.96M
• Revenue Growth: -15.79%
• P/S Ratio: 2.78
• Revenue / Employee: 1.54M
• Employees: 312
• Market Cap: 1.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	571.67M	13.62M	2.44%
Jun 30, 2023	558.05M	27.58M	5.20%
Jun 30, 2022	530.47M	26.87M	5.34%
Jun 30, 2021	503.60M	-30.43M	-5.70%
Jun 30, 2020	534.03M	-67.94M	-11.29%